3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
19
Carcinoma, Non-Small-Cell Lung
9
Rhabdomyosarcoma
6
Triple Negative Breast Neoplasms
5
Hodgkin Disease
4
Recurrence
3
Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Rhabdomyosarcoma, Embryonal
2
Rhabdomyosarcoma, Alveolar
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Adenocarcinoma
2
Solitary Fibrous Tumor, Pleural
1
NSCLC
1
Metastatic HER2-positive Breast Cancer
1
Mesothelioma, Malignant
1
Lung Diseases, Interstitial
1
Locally Advanced Non-Small Cell Lung Cancer
1
HR+HER2- Breast Cancer
1
Fludzoparib" and Anti-angiogenic
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Large Cell
1
Advanced Breast Cancer
1
Interventions
Cyclophosphamide
22
Dexamethasone
15
Cytarabine
14
venetoclax
13
Vincristine
13
Methotrexate
10
Etoposide
10
Prednisone
9
Doxorubicin
9
Calcium Dobesilate
9
prednylidene
8
dexamethasone acetate
8
dexamethasone 21-phosphate
8
deltacortene
8
auricularum
8
merphos
7
Specimen Handling
7
pegaspargase
6
fludarabine phosphate
6
daratumumab
6
calaspargase pegol
6
Mercaptopurine
6
Granulocyte Colony-Stimulating Factor
6
fludarabine
5
Stem Cell Transplantation
5
Filgrastim
5
Daunorubicin
5
Bortezomib
5
Biopsy
5
Asparaginase
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
Vinorelbine
×
1 year
×
Clear all
No trials found.